The third installment of the 2018 maize lethal necrosis (MLN) phenotyping (screening/ indexing) cycle will be held in July 2018 at the MLN artificial inoculation screening site in Naivasha, Kenya. Interested organizations from both the private and public sectors are invited to send maize germplasm for screening.
CIMMYT and partners are dedicated to stopping the spread of this deadly maize disease by effectively managing the risk of MLN on maize production through screening and identifying MLN-resistant germplasm. The MLN screening facility supports countries in sub-Saharan Africa to screen maize germplasm (for hybrid, inbred and open pollinated varieties) against MLN in a quarantined environment.
This is the largest dedicated MLN screening facility in East Africa. Since its inception in 2013, the facility has evaluated more than 120,000 accessions (more than 210,000 rows of maize) from more than 15 multinational and national seed companies and national research programs.
Partners can now plan for annual MLN Phenotyping (Screening / Indexing) during 2018 with the below mentioned schedule. The improved and streamlined approach for MLN phenotyping should enable our partners to accelerate breeding programs to improve resistance for Maize MLN for sub-Saharan Africa.
Schedule for 2018 – annual phenotyping (Indexing / Screening).